1,251 results on '"myelodysplasia"'
Search Results
2. Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
3. Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
4. TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) (1703/1801)
5. Concurrent myelodysplastic malignancies and plasma cell neoplasms; a clinicopathological study with prognostic implications.
6. Exploring p53 protein expression and its link to TP53 mutation in myelodysplasia‐related malignancies—Interpretive challenges and potential field of applications.
7. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)
8. Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients
9. Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
10. Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
11. Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDS (Bigeminy)
12. MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
13. Combining 5‐azacitidine with the E‐selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia.
14. Relapse Primary Central Nervous System Lymphoma Successfully Consolidated with Allogeneic Stem Cell Transplantation with Thiotepa/Busulfan/Fludarabine Conditioning.
15. Batimastat Induces Cytotoxic and Cytostatic Effects in In Vitro Models of Hematological Tumors.
16. Detection of dysplasia in peripheral blood: Proposal of an algorithm to detect myelodysplastic syndromes and chronic myelomonocytic leukemias on a high‐speed technical platform using the Sysmex XN™ analyser.
17. Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia
18. Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
19. Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
20. MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
21. The paucity of epidemiological data and challenges of diagnosis in myeloid neoplasms in sub‐Saharan Africa: A call for action?
22. ATG Plus PTCy vs ATG for CGVHD Prophylaxis
23. Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant (GLOBAL)
24. Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)
25. MargheRITA (Remote Intelligence for Therapeutic Adherence) (MargheRITA)
26. Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy (BIOFER12)
27. Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB)
28. Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis (APAT)
29. Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
30. Could it be VEXAS?
31. November 2023 Imaging Case of the Month: A Crazy Association
32. ProGraME: A novel flow cytometry algorithm for the diagnosis of low‐risk myelodysplastic syndromes in patients with cytopenia.
33. The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications.
34. Genetic and Familial Pulmonary Fibrosis Related to Monogenic Diseases
35. Relapsing Polychondritis
36. Evaluating Low-dose Deferasirox (DFX) in Patients With Low-risk MDS Resistant or Relapsing After ESA Agents (LODEFI)
37. Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy (SPACE2)
38. Batimastat Induces Cytotoxic and Cytostatic Effects in In Vitro Models of Hematological Tumors
39. February 2024 Medical Image of the Month: Pulmonary Alveolar Proteinosis in Myelodysplastic Syndrome
40. Unveiling the clinical spectrum of relapsing polychondritis: insights into its pathogenesis, novel monogenic causes, and therapeutic strategies
41. Decitabine, Cytarabine, GCSF for Refractory AML/MDS
42. Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project
43. French practical guidelines for the diagnosis and management of relapsing polychondritis.
44. Updates in Classification of Myelodysplastic Syndrome.
45. TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia.
46. Bone Marrow
47. Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project.
48. Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic Syndrome.
49. Ischemic myelomalacia and closed spinal dysraphism in multiple finishing swine.
50. Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.